Biofrontera AG buy krebskrebs
Start price
16.08.21
/
50%
€2.49
Target price
16.08.22
€4.00
Performance (%)
-50.80%
End price
17.08.22
€1.23
Summary
This prediction ended on 17.08.22 with a price of €1.23. The BUY prediction by krebskrebs for Biofrontera AG performed very badly with a performance of -50.80%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biofrontera AG | - | - | - | - |
| iShares Core DAX® | 0,30 % | 4,70 % | 4,54 % | 51,55 % |
| iShares Nasdaq 100 | 0,43 % | 12,26 % | 31,98 % | 98,29 % |
| iShares Nikkei 225® | 1,63 % | 12,62 % | 43,26 % | 69,87 % |
| iShares S&P 500 | 0,57 % | 7,79 % | 23,48 % | 69,79 % |
Comments by krebskrebs for this prediction
In the thread Biofrontera AG diskutieren
In the thread Trading Biofrontera AG
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten